看见一个 Expert Review of Anticancer Therapy。你们前面用依维莫斯，血、肝肾功能还好。下一步是否考虑索拉非尼+依维莫斯。供你参考。0 H2 v! X$ J0 @4 |
' f9 W a# L) N( o! s+ | c
2 Y- h5 O" w1 C" R% W9 d
Currently available feasibility data for possible combination strategies.
) w4 z& N/ D) E6 x————————————————————————————————3 L' o( _* w. R7 |
Combination Feasibility according to preliminary data 0 _) M4 s s# B- L5 k2 r# N
——————————————————————————————————
. q$ ? u6 b3 f5 B8 f; W0 b8 wBevacizumab + sorafenib Yes, reduced dose ) O' W' [( ?# ]9 g! G
Bevacizumab + sunitinib† No , ?+ f7 z( D: g: E: |5 H" k- f9 ^
Bevacizumab + temsirolimus Yes
) V* O$ ]$ m1 ~' z4 h% HBevacizumab + everolimus Yes 3 D0 V: O" l$ G* R
Sorafenib + sunitinib ? 9 a. U- [7 R6 ^' W- Z
Sorafenib + temsirolimus Yes, reduced dose ( E3 Z7 d# Z: A3 y5 r9 n
Sorafenib + everolimus Yes, reduced dose
- m/ Q, W) x: u0 g% }" S tSunitinib + temsirolimus† No
+ }7 C4 z% T& h- ASunitinib + everolimus ? & z2 R! @) I% p* s0 F2 G% C, @
Temsirolimus + everolimus ?
$ F' Z2 I# D" m: ^————————————————————- A0 g N6 A& {6 R
†Led to US FDA warning.
9 w p6 H, [; Z9 b- m?: As yet unattempted combination.
% ]9 F9 _/ O$ H$ \ |
显身卡
7 Z- H% h. J* Q; h' x2 _8 r
